« Return to News | CROs/Service Providers | Study Conduct

Russia's clinical trials are a thriving business

Friday, March 18, 2011 01:31 PM

ClinStar, a CRO providing clinical research services in Russia and Eastern Europe, discussed the benefits of conducting clinical trials in Russia in an interview with NPR Marketplace health desk reporter Gregory Warner.

Warner reported the clinical trial industry in Russia is growing by 15%. ClinStar president and CEO David Passov said the advantages of clinical trials in Russia is the ability for biopharmaceutical companies to enroll patients three to 20 times faster than in North America and Western Europe.

Passov said, “The clinical trial industry has been well established in North America and Western Europe for the last 25 years or so now. For many who are not familiar with clinical trials and the drug development process, Russia is considered to be an emerging region for clinical trial conduct. By most definitions, however, Russia is not an emerging country for clinical trials but rather a well established country for conducting clinical research.”

“In an era where the costs to develop a drug are greater than $1 billion, and only an estimated one in 5,000 compounds ever make it to market, the benefits of conducting clinical trials in Russia are too great to ignore,” said executive director of business development and marketing Erin King. “By speeding up the patient enrollment process, biopharmaceutical companies are able to shrink the clinical trial timeline and reduce the overall costs to get a drug approved.”

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.